Clinical biomarkers differentiate myelitis from vascular and other causes of myelopathy

Neurology

Volumn 90, Issue 1, 2018, Pages E12-E21

  Barreras, Paula ^a   Fitzgerald, Kathryn C ^a   Mealy, Maureen A ^a   Jimenez, Jorge A ^b,c   Becker, Daniel ^a,d   Newsome, Scott D ^a   Levy, Michael ^a   Gailloud, Philippe ^a   Pardo, Carlos A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^c Neuroclinica   (Colombia)

^d International Neurorehabilitation Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GADOLINIUM;

ADULT; AGED; ARTERIOVENOUS FISTULA; ARTERIOVENOUS MALFORMATION; ARTICLE; BRAIN ISCHEMIA; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COHORT ANALYSIS; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PLEOCYTOSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; SPINAL CORD DISEASE; VASCULAR DISEASE; CEREBROSPINAL FLUID; CLASSIFICATION; DIAGNOSTIC IMAGING; DISEASE EXACERBATION; MIDDLE AGED; NEUROLOGIC EXAMINATION; RETROSPECTIVE STUDY; SPINAL CORD; TIME FACTOR;

ADULT; AGED; BIOMARKERS; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYELITIS, TRANSVERSE; NEUROLOGIC EXAMINATION; RETROSPECTIVE STUDIES; SPINAL CORD; SPINAL CORD DISEASES; TIME FACTORS;

EID: 85050210006     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000004765     Document Type: Article

References (22)

1. Beh SC, Greenberg BM, Frohman T, Frohman EM. Transverse myelitis. Neurol Clin 2013;31:79-138.
2. Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 2002;59:499-505.
3. Bazerbachi F, Maiser S, Clark HB. Giant thoracic schwannoma masquerading as transverse myelitis. QJM 2013;106:759-761.
4. Flanagan EP, Krecke KN, Marsh RW, et al. Specific pattern of gadolinium enhancement in spondylotic myelopathy. Ann Neurol 2014;76:54-65.
5. Bee YJ, Lee JW, Park KS, et al. Compressive myelopathy: magnetic resonance imaging findings simulating idiopathic acute transverse myelopathy. Skeletal Radiol 2013;42: 793-782.
6. Matsubayashi J, Tsuchiya K, Shimizu S, et al. Posterior spinal artery syndrome showing marked swelling of the spinal cord: a clinico-pathological study. J Spinal Cord Med 2013;36:31-35.
7. Lee YJ, Terbrugge KG, Saliou G, Krings T. Clinical features and outcomes of spinal cord arteriovenous malformations: comparison between nidus and fistulous types. Stroke 2014;45:2606-2612.
8. Lee CS, Pyun HW, Chae EY, Kim KK, Rhim SC, Suh DC. Reversible aggravation of neurological deficits after steroid medication in patients with venous congestive myelopathy caused by spinal arteriovenous malformation. Interv Neuroradiol 2009; 15:325-329.
9. Schmalstieg WF, Weinshenker BG. Approach to acute or subacute myelopathy. Neurology 2010;75(suppl 1):S2-S8.
10. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292-302.
11. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-1489.
12. Zajicek JP, Scolding NJ, Foster O, et al. Central nervous system sarcoidosis: diagnosis and management. Q JM 1999;92:103-117.
13. Birnbaum J, Petri M, Thompson R, Izbudak I, Kerr D. Distinct subtypes of myelitis in systemic lupus erythematosus. Arthritis Rheum 2009;60:3378-3387.
14. Gailloud P, Gregg L, Galan P, Becker D, Pardo C. Periconal arterial anastomotic circle and posterior lumbosacral watershed zone of the spinal cord. J Neurointerv Surg 2015;7:848-853.
15. Li J, Jiang B, Fine JP. Multicategory reclassification statistics for assessing improvements in diagnostic accuracy. Biostatistics 2013;14:382-394.
16. Li J, Fine JP. ROC analysis with multiple classes and multiple tests: methodology and its application in microarray studies. Biostatistics 2008;9:566-576.
17. Frohman EM, Wingerchuk DM. Transverse myelitis. N Engl J Med 2010;363: 564-572.
18. Novy J, Carruzzo A, Maeder P, Bogousslavsky J. Spinal cord ischemia: clinical and imaging patterns, pathogenesis, and outcomes in 27 patients. Arch Neurol 2006;63: 1113-1120.
19. Wong JJ, Dufton J, Mior SA. Spontaneous conus medullaris infarction in a 79-year-old female with cardiovascular risk factors: a case report. J Can Chiropr Assoc 2012;56: 58-65.
20. Jellema K, Canta LR, Tijssen CC, van Rooij WJ, Koudstaal PJ, van Gijn J. Spinal dural arteriovenous fistulas: clinical features in 80 patients. J Neurol Neurosurg Psychiatry 2003;74:1438-1440.
21. Liu HS, Chung HW, Chou MC, et al. Effects of microvascular permeability changes on contrast-enhanced T1 and pharmacokinetic MR imaging after ischemia. Stroke 2013; 44:1872-1877.
22. Karonen JO, Partanen PL, Vanninen RL, Vainio PA, Aronen HJ. Evolution of MR contrast enhancement patterns during the first week after acute ischemic stroke. AJNR Am J Neuroradiol 2001;22:103-111.